Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13-week Phase 3 study of naproxcinod vs placebo and naproxen in osteoarthritis of the hip
2007-000078-21Phase 3Completed
- Sponsor
- Nicox S.A.
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of naproxcinod in hip osteoarthritis (3 arms), sponsored by Nicox S.A. Started Jul 2007; status: completed.
02
Drugs
naproxcinod
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on 2007-000078-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000078-21.